These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 32775036)

  • 1. Treatment of Secondary Chorea: A Review of the Current Literature.
    Feinstein E; Walker R
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():22. PubMed ID: 32775036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deutetrabenazine for tardive dyskinesia and chorea associated with Huntington's disease: a review of clinical trial data.
    Claassen DO; Philbin M; Carroll B
    Expert Opin Pharmacother; 2019 Dec; 20(18):2209-2221. PubMed ID: 31613641
    [No Abstract]   [Full Text] [Related]  

  • 3. Profiling deutetrabenazine extended-release tablets for tardive dyskinesia and chorea associated with Huntington's disease.
    Moondra P; Jimenez-Shahed J
    Expert Rev Neurother; 2024 Sep; 24(9):849-863. PubMed ID: 38982802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VMAT2 inhibitors for the treatment of hyperkinetic movement disorders.
    Koch J; Shi WX; Dashtipour K
    Pharmacol Ther; 2020 Aug; 212():107580. PubMed ID: 32454050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VMAT2 Inhibitors for Tardive Dyskinesia-Practice Implications.
    Peckham AM; Nicewonder JA
    J Pharm Pract; 2019 Aug; 32(4):450-457. PubMed ID: 29455579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention and treatment of tardive dyskinesia caused by antipsychotic drugs].
    Seigneurie AS; Sauvanaud F; Limosin F
    Encephale; 2016 Jun; 42(3):248-54. PubMed ID: 26922134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment options for chorea.
    Bashir H; Jankovic J
    Expert Rev Neurother; 2018 Jan; 18(1):51-63. PubMed ID: 29120264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. deutetrabenazine for the treatment of chorea associated with Huntington's disease.
    Gupta H; Perkins W; Stark C; Kikkeri S; Kakazu J; Kaye A; Kaye AD
    Health Psychol Res; 2022; 10(5):36040. PubMed ID: 35774908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Chorea in Childhood.
    Yilmaz S; Mink JW
    Pediatr Neurol; 2020 Jan; 102():10-19. PubMed ID: 31604647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine depleters in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Expert Opin Pharmacother; 2016 Dec; 17(18):2461-2470. PubMed ID: 27819145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Role of Deutetrabenazine in the Treatment of Chorea Linked with Huntington's Disease.
    Tripathi S; Sharma Y; Kumar D
    Curr Rev Clin Exp Pharmacol; 2024 Oct; ():. PubMed ID: 39415318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valbenazine for the treatment of tardive dyskinesia.
    Seeberger LC; Hauser RA
    Expert Opin Pharmacother; 2017 Aug; 18(12):1279-1287. PubMed ID: 28699794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Idiopathic (Oral) and Tardive Dyskinesia: Pathogenesis, Epidemiology, and Treatment].
    Mukai Y
    Brain Nerve; 2023 Jan; 75(1):23-35. PubMed ID: 36574970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological treatment of chorea in Huntington's disease-good clinical practice versus evidence-based guideline.
    Reilmann R
    Mov Disord; 2013 Jul; 28(8):1030-3. PubMed ID: 23674480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-Induced Dyskinesia, Part 2: Treatment of Tardive Dyskinesia.
    Vijayakumar D; Jankovic J
    Drugs; 2016 May; 76(7):779-87. PubMed ID: 27091214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Update on the Treatment of Chorea.
    Feinstein E; Walker R
    Curr Treat Options Neurol; 2018 Sep; 20(10):44. PubMed ID: 30255459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A blinded study of the suppressibility of involuntary movements in Huntington's chorea, tardive dyskinesia, and L-dopa-induced chorea.
    Walters AS; McHale D; Sage JI; Hening WA; Bergen M
    Clin Neuropharmacol; 1990 Jun; 13(3):236-40. PubMed ID: 2141544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Updating the recommendations for treatment of tardive syndromes: A systematic review of new evidence and practical treatment algorithm.
    Bhidayasiri R; Jitkritsadakul O; Friedman JH; Fahn S
    J Neurol Sci; 2018 Jun; 389():67-75. PubMed ID: 29454493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Utility of Deutetrabenazine as a Treatment Option for Chorea Associated with Huntington's Disease and Tardive Dyskinesia.
    Frank S; Alakkas A
    Ther Clin Risk Manag; 2023; 19():1019-1024. PubMed ID: 38074485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington disease and other choreas.
    Cardoso F
    Neurol Clin; 2009 Aug; 27(3):719-36, vi. PubMed ID: 19555828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.